search

Active clinical trials for "Syndrome"

Results 81-90 of 9759

Sirolimus for Cowden Syndrome With Colon Polyposis

PTEN Gene MutationPTEN Hamartoma Tumor Syndrome5 more

Colon polyposis (the presence of multiple colon polyps) is very common with Cowden syndrome, as over 60% of patients have 50 or more polyps. In a previous clinical trial, some participants had reduction in the number of colon polyps with the use of the medication sirolimus for a very short time period. This study is investigating sirolimus and its effect on the number of colon polyps in patients with Cowden syndrome and polyposis over a 1 year period.

Recruiting10 enrollment criteria

Interactions of Medicine and Exercise With Meal Timing

Metabolic SyndromeProtection Against7 more

To analyze the effects of altering the time of ingestion of participants' habitual medication (i.e., metformin, statins, ARAII/IACE) and meals around the time of exercise training (exercise fasted or fed) on the improvement of metabolic syndrome factors (hypertension, insulin sensitivity, dyslipidemia, and obesity). There will be a preliminary study of the effects of training "time-of-day" on the primary study outcomes.

Recruiting5 enrollment criteria

Assessment of Adjunctive Cannabidiol Oral Solution (GWP42003-P) in Children With Tuberous Sclerosis...

Seizure in Participants With Tuberous Sclerosis ComplexSeizure in Participants With Dravet Syndrome1 more

This study will be conducted to evaluate the safety, pharmacokinetics (PK), and efficacy of adjunctive GWP42003-P in participants < 2 years of age with tuberous sclerosis complex (TSC), Lennox-Gastaut syndrome (LGS), or Dravet syndrome (DS).

Recruiting24 enrollment criteria

BXCL701 Phase 1 R/R Acute Myeloid Leukemia or Myelodysplastic Syndrome

Acute Myeloid LeukemiaMyelodysplastic Syndrome With Excess Blasts-2

The goal of this research study is to find the safest and most effective dose of the study drug, BXCL701, for the treatment of Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS). The names of the study drugs involved in this study are/is: BXCL701

Recruiting37 enrollment criteria

Ilium Mobilization in Patellofemoral Pain Syndrome Treatment

Patellofemoral Pain Syndrome

Aim of the study is to investigate the effect of adding posterior ilium mobilization on knee pain, knee function, anterior pelvic tilt, dynamic knee valgus, muscle strength of extensors, abductors and external rotators of hip and knee extensors in patients with patellofemoral pain syndrome.

Recruiting14 enrollment criteria

A Phase 3 Clinical Study to Evaluate Lemzoparlimab for Injection in Combination With Azacitidine...

Myelodysplastic Syndromes(MDS)

This phase3 study is a randomized, controlled, open-label, multicenter study to evaluate the efficacy and safety of Lemzoparlimab for injection in combination with AZA versus AZA monotherapy as first-line therapy in treatment-naïve subjects with intermediate- and high-risk MDS.

Recruiting16 enrollment criteria

Study of INV-202 in Patients With Obesity and Metabolic Syndrome

ObesityMetabolic Syndrome

The study is designed to assess the efficacy, safety, tolerability, and transformation within the human body of INV-202 investigational drug in the treatment of adult participants with obesity and metabolic syndrome.

Recruiting25 enrollment criteria

Bowen and Graston Technique in Patients of Tension Neck Syndrome

Neck Syndrome

To compare the effects of Bowen and Graston technique in Tension neck syndrome for neck pain , ROM and disability in patients with Tension neck syndrome .

Recruiting12 enrollment criteria

Safety and Efficacy of a Probiotic Supplement in IBS-D

Irritable Bowel Syndrome With DiarrheaIrritable Bowel Syndrome

This study aims to assess the safety and efficacy of a single probiotic strain on symptom severity in patients with diarrhea-predominant Irritable Bowel Syndrome (IBS-D).

Recruiting35 enrollment criteria

Comparison of INRECSURE and LISA in Preterm Neonates With RDS

Respiratory Distress SyndromeBronchopulmonary Dysplasia

The primary hypothesis of this study is that surfactant administration by INtubate-RECruit-SURfactant-Extubate (IN-REC-SUR-E), via a high frequency oscillatory ventilation recruitment maneuver increases survival without BPD at 36 weeks' gestational age in spontaneously breathing infants born at 24+0-27+6 weeks' gestation affected by Respiratory Distress Syndrome (RDS) and failing nasal CPAP or nasal intermittent positive pressure ventilation (NIPPV) during the first 24 hours of life compared to less invasive surfactant administration (LISA).

Recruiting11 enrollment criteria
1...8910...976

Need Help? Contact our team!


We'll reach out to this number within 24 hrs